WHC is still in active development. Read this to understand our approach.
depiction of SUHOQUVVVLNYQR-UHFFFAOYSA-N.svg
psychonaut

Alpha-GPC

Check on psychonaut

drugmap

Choline alfoscerate

Check on drugmap

drugmap

Choline alfoscerate

Check on drugmap

wiki

Glycerophosphorylcho...

Check on wiki

Data

InChI: InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3

Synonyms: L-a-GPC,HMS2233P21,alpha-Glycerophosphorylcholine,L-1-glycero-3-phosphocholine, Glycerophosphate de choline,2-[[(2,3-dihydroxypropoxy)hydroxyphosphinyl]oxy]-N,N,N-trimethyl-Ethanaminium inner salt,alpha-Glyceryl phosphoryl choline, Alfoscerato de colina, GPCho,(2R)-2,3-dihydroxypropyl 2-(trimethylammonio)ethyl phosphate, UNII-60M22SGW66,60M22SGW66,CHOLINE ALFOSCERATE [MART.],Epitope ID:150907,AS-13724,Cholini glycerophosphas,(2-{[(2R)-2,3-dihydroxypropyl phosphonato]oxy}ethyl)trimethylazanium,UNII-60M22SGW66,MLS000069588,Glycerophosphorylcholine, glycerol-3-phosphocholine,glycero-phosphocholine,CHEMBL1567463, Choline glycerophosphate,a-Glycerophosphorylcholine,L-alpha-Glycerophosphocholine, L-alpha-Glycerophosphorylcholine,Glycerol 3-phosphocholine, Choline Alfoscerate,Ethanaminium,2-[[[(2R)-2,3-dihydroxypropoxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, innersalt,Choline Alfoscerate,CHEBI:16870, Glicerofosfato de colina,L-A-glycerophosphorylcholine,(2R)-2,3-dihydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate,glycerol-3-phosphocholine, L-alpha-Glycerophosphocholine, Choline Alphoscerate,Opera_ID_471,2-{[(2R)-2,3-dihydroxypropoxy](hydroxy)phosphoryloxy}-N,N,N-trimethylethanaminium, Glycerol phosphorylcholine,Cholini alfosceras [INN-Latin], alpha-Glycerophosphorylcholine,Delecit (TN),Glycerophosphocholine; LC-tDDA; CE10, Glycerophosphocholine,Ethanaminium, 2-(((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt, (R)-,DB04660,Choline alfoscerate [INN],L-Choline hydroxide 2,3-dihydroxypropyl hydrogen phosphate inner salt,sn-Glycerophosphorylcholine (egg, free base),AC7982,CHOLINE ALFOSCERATE [MI],Glicerofosfato de colina,D07349,Glycerophosphocholine,HMS3887O13,Gliatilin,SMR000058753,SN-glycero-3-phosphocholine,Calcium (glycerophosphate de) [DCF], Cholini glycerophosphas,Choline alfoscerate (INN),Sn-3-GPC,L-ALPHA-GLYCERYLPHOSPHORYLCHOLINE [USP-RS],GLYCEROPHOSPHOCHOLINE [INCI],CCG-267031,AKOS005762883,Gliatilin (TN),Colina glicerofosfato,Glycerol-3-phosphatidylcholine,Cholini glycerophosphas [Latin],Choline hydroxide, (R)-2,3-dihydroxypropyl hydrogen phosphate, inner salt,Glicerofosfato de colina [Spanish],SCHEMBL63754,H10892,Glycerophosphate de choline,28319-77-9,CHOLINE ALFOSCERATE [WHO-DD],BRN 6062450,Choline Alphoscerate,HY-17552,ACT03312,L-alpha-Glycerophosphorylcholine,L-1-glycero-phosphorylcholine,Glycerophosphatidylcholine,Choline, hydroxide, 2,3-dihydroxypropyl hydrogen phosphate, inner salt, D-,MFCD00063544, Glycerophosphorylcholine,Calcium (glycerophosphate de),CHEBI:55397, Sn-3-GPC,(R)-2-[[(2,3-Dihydroxypropoxy)hydroxyphosphinyl]oxy]-N,N,N-trimethylethanaminium Inner Salt, 28319-77-9,alpha-Glycerylphosphorylcholine,Q28529699,DTXSID70951010, L-alpha-Glycerylphosphorylcholine,sn-glycerol 3-phosphocholine,AMY40024,L-.ALPHA.-GLYCERYLPHOSPHORYLCHOLINE,a-Glycerylphosphorylcholine,hydrogen glycerophosphate Choline,(R)-2,3-Dihydroxypropyl (2-(trimethylammonio)ethyl) phosphate,563-23-5, SN-glycero-3-phosphocholine,ETHANAMINIUM, 2-((((2R)-2,3-DIHYDROXYPROPOXXY)HYDROXYPHOSPHINYL)OXY)-N,N,N-TRIMETHYL-, INNER SALT,Alfoscerato de colina,GPCho,Choline glycerophosphate,L-alpha-Glycerylphosphorylcholine,EINECS 248-962-2,Glycerol phosphorylcholine,Alfoscerato de colina [INN-Spanish],Cholini alfosceras,EX-A979,Alfoscerate de choline [INN-French],Alfoscerate de choline,brezal,(R)-2,3-dihydroxypropyl 2-(trimethylammonio)ethyl phosphate,Glycerophosphate de choline [French]


Estimated data

Solubility: 0.438 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 47.9% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.